A case study of polypharmacy management in nine European countries: Implications for change management and implementation.
<h4>Background</h4>Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (EU); why programs were, or were not, develo...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2018-01-01
|
| Серія: | PLoS ONE |
| Онлайн доступ: | https://doi.org/10.1371/journal.pone.0195232 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
